Erasca, Inc. Balance Sheet
ERAS / Health Care|5 years of annual SEC 10-K data (FY2020-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Erasca, Inc. had $503M in total assets and $423M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | $67.7M | $93.1M | $284.2M | $360.5M | $65.4M |
| Current Assets | $308.8M | $320.7M | $444.5M | $420.0M | $120.0M |
| PP&E (Net) | $16.3M | $22.3M | $24.8M | $16.0M | $1.8M |
| Total Assets | $502.5M | $395.3M | $514.9M | $501.4M | $124.8M |
| Current Liabilities | $31.4M | $26.2M | $48.7M | $26.2M | $13.7M |
| Shareholders' Equity | $423.5M | $316.7M | $411.9M | $456.5M | -$114.0M |